Literature DB >> 15581831

DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.

S E Flores-Martínez1, S Islas-Andrade, M V Machorro-Lazo, M C Revilla, R E Juárez, K I Mújica-López, M C Morán-Moguel, M G López-Cardona, J Sánchez-Corona.   

Abstract

Type 2 diabetes mellitus is a complex metabolic disorder resulting from the action and interaction of many genetic and environmental factors. It has been reported that polymorphisms in genes involved in the metabolism of glucose are associated with the susceptibility to develop type 2 diabetes mellitus. Although the risk of developing type 2 diabetes mellitus increases with age, as well as with obesity and hypertension, its prevalence and incidence are different among geographical regions and ethnic groups. In Mexico, a higher prevalence and incidence has been described in the south of the country, and differences between urban and rural communities have been observed. We studied 73 individuals from Santiago Jamiltepec, a small indigenous community from Oaxaca State, Mexico. This population has shown a high prevalence of type 2 diabetes mellitus, and the aim of this study was to analyze the relationship between the Pst I (insulin gene), Nsi I (insulin receptor gene) and Gly972Arg (insulin receptor substrate 1 gene) polymorphisms and type 2 diabetes mellitus, obesity and hypertension in this population. Clinical evaluation consisted of BMI and blood pressure measurements, and biochemical assays consisted of determination of fasting plasma insulin and glucose levels. PCR and restriction enzyme digestion analysis were applied to genomic DNA to identify the three polymorphisms. From statistical analysis carried out here, individually, the Pst I, Nsi I and Gly972Arg polymorphisms were not associated with the type 2 diabetes, obese or hypertensive phenotypes in this population. Nevertheless, there was an association between the Nsi I and Pst I polymorphisms and increased serum insulin levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581831     DOI: 10.1016/j.anngen.2004.05.004

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  6 in total

1.  Associations between two single-nucleotide polymorphisms (rs1801278 and rs2943641) of insulin receptor substrate 1 gene and type 2 diabetes susceptibility: a meta-analysis.

Authors:  Qiuyan Li; Yuandong Qiao; Chuntao Wang; Guangfa Zhang; Xuelong Zhang; Lidan Xu
Journal:  Endocrine       Date:  2015-11-18       Impact factor: 3.633

2.  Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.

Authors:  Bo Zhu; Xiaomei Wu; Xueyuan Zhi; Lei Liu; Quanmei Zheng; Guifan Sun
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

3.  Meta-analysis of associations between TCF7L2 polymorphisms and risk of type 2 diabetes mellitus in the Chinese population.

Authors:  Jinjin Wang; Fulan Hu; Tianping Feng; Jingzhi Zhao; Lei Yin; Linlin Li; Yan Wang; Qian Wang; Dongsheng Hu
Journal:  BMC Med Genet       Date:  2013-01-12       Impact factor: 2.103

4.  Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status.

Authors:  Habiba Alsafar; Ahmed Hassoun; Shaikha Almazrouei; Wala Kamal; Mustafa Almaini; Unini Odama; Naushad Rais
Journal:  Dis Markers       Date:  2015-09-29       Impact factor: 3.434

5.  Combined association analysis of interleukin 1-receptor antagonist (IL-1RN) variable number of tandem repeat (VNTR) and Haptoglobin 1/2 polymorphisms with type 2 diabetes mellitus risk.

Authors:  Habiba Al-Safar; Wala Kamal; Ahmed Hassoun; Wael Almahmeed; Naushad Rais
Journal:  J Diabetes Metab Disord       Date:  2016-03-29

6.  Association of vitamin D receptor gene variants with polycystic ovary syndrome: A case control study.

Authors:  Touraj Mahmoudi; Keivan Majidzadeh-A; Hamid Farahani; Mojgan Mirakhorli; Reza Dabiri; Hossein Nobakht; Asadollah Asadi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2015-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.